Simon raised FFO guidance while Surgery Partners held its year band
Simon raised real estate FFO guidance after a stronger quarter while Surgery Partners reaffirmed full-year targets despite a loss, two operators framing mixed results through guidance.
Economics & Markets··Midday
Simon's FFO lift and raised band
Simon, the real estate investment trust that owns shopping, dining and mixed-use destinations, reported results for the quarter ended 30 June on 10 August. Real Estate Funds From Operations were 1.249 billion dollars, or 3.29 dollars per diluted share, against 1.154 billion dollars and 3.05 dollars a year earlier, an increase of 7.9 per cent. The company raised its full-year 2026 outlook for real estate FFO per diluted share to a range of 13.20 dollars to 13.30 dollars. Chief Executive, President and Chief Operating Officer Eli Simon attributed the quarter to broad-based leasing demand, accelerating traffic, retailer sales growth and acquisitions completed over the past year. The public line the company moved was the full-year real estate FFO per share band after that stronger FFO print. Property-trust readers therefore see a clear sequence: quarterly FFO increased, and management moved the published 2026 range with it. The figures that matter are the 7.9 per cent FFO increase and the new 13.20 dollars to 13.30 dollars full-year range for comparison with the healthcare operator that follows.[1]
Surgery Partners grows, loses and reaffirms
Surgery Partners, which owns and operates short-stay surgical facilities, reported results for the quarter ended 30 June on 10 August. Revenue rose 2.7 per cent from a year earlier. Net loss attributable to the company was 15.0 million dollars and adjusted EBITDA was 125.2 million dollars. The company reaffirmed its full-year 2026 outlook for revenue in a range of 3.35 billion dollars to 3.45 billion dollars and adjusted EBITDA of at least 530 million dollars, excluding the effect of the pending sale of its facilities in Idaho Falls. Chief Executive Eric Evans called the Idaho Falls transaction a step in portfolio optimisation. Chief Financial Officer Dave Doherty said the sale would improve cash conversion and reduce leverage once closing conditions are met, including physician member and governing board approvals. The year band did not move even though the quarter shows a net loss beside modest revenue growth, and a facility sale is treated as portfolio work rather than a rewrite of the outlook. The material numbers are the 2.7 per cent revenue increase, the 15.0 million dollars net loss, the 125.2 million dollars adjusted EBITDA, and the held 3.35 billion dollars to 3.45 billion dollars revenue band with adjusted EBITDA of at least 530 million dollars.[2]
Guidance as the organising line
The two second-quarter releases share a reporting date and a focus on full-year 2026 guidance, yet they frame operating strength differently. Simon increased real estate FFO by 7.9 per cent and moved the year-end FFO-per-share band to 13.20 dollars to 13.30 dollars. Surgery Partners posted 2.7 per cent revenue growth beside a 15.0 million dollars net loss and 125.2 million dollars adjusted EBITDA, and kept revenue guidance at 3.35 billion dollars to 3.45 billion dollars with adjusted EBITDA of at least 530 million dollars. Eli Simon pointed to leasing demand, traffic, retailer sales and acquisitions; Eric Evans and Dave Doherty pointed to portfolio work, cash conversion and leverage once Idaho Falls closes. For readers comparing property and healthcare operators in the same window, the common thread is how each company used guidance to organise mixed quarterly results. No shared customer base joins the two releases; the joining element is where the published full-year band sits beside the quarterly print. One operator moved the band after stronger FFO; the other reaffirmed the band while reporting growth and a loss.[1], [2]
